Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains
- 1 May 2000
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 146 (5) , 1085-1090
- https://doi.org/10.1099/00221287-146-5-1085
Abstract
Antibiotics are commonly used as growth promoters in animal husbandry worldwide. This practice has been linked to the emergence of particular antibiotic-resistant bacteria, and is now controversial. In this study, the ability of growth-promoting antibiotics to induce Shiga toxin (Stx)-converting bacteriophages from Stx-producing Escherichia coli (STEC) strains was investigated. Subinhibitory concentrations of the antibacterial growth promoters olaquindox, carbadox, tylosin and monensin were used for induction experiments. The amount of mature Stx-converting phage particles released from induced and non-induced cultures was determined, and the production of Stx was simultaneously measured by ELISA. Whereas the quinoxaline-1,4-dioxide-type antibiotics olaquindox and carbadox enhanced the release of Stx-converting phage particles from STEC cells, tylosin and monensin decreased phage induction. The production of Stx increased or decreased simultaneously with the amount of free phages. The results of this study show that particular antibacterial growth promoters can induce Stx phages. In vivo induction of Stx phages from lysogenic STEC may increase the amount of free phages in the intestine and therefore may contribute to the spread of STEC and development of new STEC pathotypes.Keywords
This publication has 20 references indexed in Scilit:
- Influence of RecA onin vivovirulence and Shiga toxin 2 production inEscherichia colipathogensMicrobial Pathogenesis, 1999
- The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elementsMicrobiology, 1999
- A comparison of the effects of verocytotoxin-1 on primary human renal cell culturesToxicology Letters, 1999
- Non‐O157:H7 Pathogenic Shiga Toxin–ProducingEscherichia coli:Phenotypic and Genetic Profiling of Virulence Traits and Evidence for ClonalityThe Journal of Infectious Diseases, 1999
- Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial AgentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Functional and genetic analysis of regulatory regions of coliphage H‐19B: location of shiga‐like toxin and lysis genes suggest a role for phage functions in toxin releaseMolecular Microbiology, 1998
- Medical Consequences of Antibiotic Use in AgricultureScience, 1998
- Outbreaks of enterohaemorrhagic Escherichia colt O157:H7 infection by two different genotype strains in Japan, 1996The Lancet, 1996
- A STATEWIDE OUTBREAK OF ESCHERICHIA COLI 0157: H7 INFECTIONS IN WASHINGTON STATEAmerican Journal of Epidemiology, 1990
- Some pharmacokinetic observations of carbadox medication in pigsVeterinary Quarterly, 1988